| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.003 | 0.851 | Vasodilator, coronary | 0.457 0.022 CID_128753 | ||
| 0.85 | 0.003 | 0.85 | Vasodilator, peripheral | 0.578 0.018 CID_128753 | ||
| 0.808 | 0.001 | 0.808 | Calcium channel activator | 0.621 0.002 CID_128753 | ||
| 0.801 | 0.003 | 0.801 | Calcium channel blocker | 0.578 0.004 CID_128753 | ||
| 0.763 | 0.001 | 0.763 | Calcium antagonist | 0.342 0.004 CID_128753 | ||
| 0.751 | 0.004 | 0.751 | Vasodilator | 0.447 0.016 CID_128753 | ||
| 0.74 | 0.002 | 0.74 | Calcium channel L-type activator | 0.739 0.002 CID_128753 | ||
| 0.717 | 0.002 | 0.717 | TRPA1 agonist | 0.177 0.017 CID_128753 | ||
| 0.664 | 0.002 | 0.664 | Calcium channel L-type blocker | 0.463 0.003 CID_128753 | ||
| 0.657 | 0.003 | 0.657 | Calcium channel (voltage-sensitive) blocker | 0.402 0.004 CID_128753 | ||
| 0.592 | 0.008 | 0.592 | Cardiotonic | 0.195 0.124 CID_128753 | ||
| 0.389 | 0.005 | 0.389 | Alpha 2b adrenoreceptor antagonist | 0.229 0.018 CID_128753 | ||
| 0.458 | 0.098 | 0.56 | DNA polymerase beta inhibitor | 0.56 0.069 CID_128753 | CID_128753 | |
| 0.35 | 0.026 | 0.35 | Cyclic AMP phosphodiesterase inhibitor | 0.232 0.073 CID_128753 | ||
| 0.309 | 0.006 | 0.309 | Adenylate kinase inhibitor | 0.166 0.021 CID_128753 | ||
| 0.353 | 0.052 | 0.353 | Spasmolytic | |||
| 0.313 | 0.02 | 0.313 | Diuretic | |||
| 0.339 | 0.049 | 0.339 | Hypoxia-inducible factor 1 alpha inhibitor | 0.27 0.083 CID_128753 | ||
| 0.316 | 0.032 | 0.316 | Platelet aggregation inhibitor | |||
| 0.288 | 0.007 | 0.288 | Alpha 2c adrenoreceptor antagonist | 0.182 0.022 CID_128753 | ||
| 0.394 | 0.118 | 0.497 | DNA directed DNA polymerase inhibitor | 0.497 0.083 CID_128753 | CID_128753 | |
| 0.278 | 0.003 | 0.278 | Aldosterone antagonist | 0.048 0.032 CID_128753 | ||
| 0.27 | 0.005 | 0.27 | CF transmembrane conductance regulator agonist | 0.152 0.072 CID_128753 | ||
| 0.269 | 0.007 | 0.269 | Neuropeptide Y1 antagonist | 0.257 0.008 CID_128753 | ||
| 0.295 | 0.033 | 0.295 | 5 Hydroxytryptamine 1E antagonist | 0.234 0.092 CID_128753 | ||
| 0.288 | 0.031 | 0.288 | P-glycoprotein inhibitor | 0.199 0.064 CID_128753 | ||
| 0.361 | 0.125 | 0.437 | Transcription factor inhibitor | 0.437 0.095 CID_128753 | CID_128753 | |
| 0.312 | 0.095 | 0.375 | Thioredoxin glutathione reductase inhibitor | 0.375 0.067 CID_128753 | CID_128753 | |
| 0.29 | 0.081 | 0.29 | Interleukin 2 agonist | 0.257 0.111 CID_128753 | ||
| 0.276 | 0.069 | 0.621 | Aryl hydrocarbon receptor agonist | 0.621 0.013 CID_128753 | CID_128753 | |
| 0.199 | 0.004 | 0.199 | Glycine receptor antagonist | 0.078 0.06 CID_128753 | ||
| 0.215 | 0.023 | 0.292 | Mannose-6-phosphate isomerase inhibitor | 0.292 0.006 CID_128753 | CID_128753 | |
| 0.343 | 0.151 | 0.492 | Caspase 9 stimulant | 0.492 0.063 CID_128753 | CID_128753 | |
| 0.284 | 0.104 | 0.284 | Transcription factor NF kappa B inhibitor | 0.264 0.118 CID_128753 | ||
| 0.188 | 0.015 | 0.188 | Androgen antagonist | 0.1 0.047 CID_128753 | ||
| 0.187 | 0.016 | 0.187 | Alpha 1b adrenoreceptor antagonist | |||
| 0.176 | 0.012 | 0.176 | Alpha 1d adrenoreceptor antagonist | |||
| 0.212 | 0.05 | 0.212 | Amyloid beta precursor protein antagonist | 0.146 0.106 CID_128753 | ||
| 0.177 | 0.017 | 0.177 | Alpha 2a adrenoreceptor antagonist | |||
| 0.198 | 0.042 | 0.203 | Interleukin 6 antagonist | 0.203 0.039 CID_128753 | CID_128753 | |
| 0.222 | 0.072 | 0.222 | RNA-directed DNA polymerase inhibitor | 0.214 0.081 CID_128753 | ||
| 0.264 | 0.115 | 0.264 | Apoptosis antagonist | |||
| 0.184 | 0.039 | 0.241 | GABA C receptor rho-2 antagonist | 0.241 0.014 CID_128753 | CID_128753 | |
| 0.164 | 0.019 | 0.164 | Beta glucuronidase inhibitor | 0.121 0.045 CID_128753 | ||
| 0.204 | 0.068 | 0.239 | Non-steroidal antiinflammatory agent | 0.239 0.047 CID_128753 | CID_128753 | |
| 0.137 | 0.005 | 0.137 | Mineralocorticoid receptor antagonist | |||
| 0.268 | 0.137 | 0.286 | Calpain 2 inhibitor | 0.286 0.123 CID_128753 | CID_128753 | |
| 0.219 | 0.089 | 0.219 | Platelet antagonist | |||
| 0.183 | 0.055 | 0.301 | Cytidine deaminase inhibitor | 0.301 0.019 CID_128753 | CID_128753 | |
| 0.225 | 0.098 | 0.225 | Interleukin agonist | 0.223 0.1 CID_128753 | ||
| 0.148 | 0.022 | 0.178 | DOPA decarboxylase inhibitor | 0.178 0.011 CID_128753 | CID_128753 | |
| 0.135 | 0.014 | 0.135 | Adenosine A3 receptor antagonist | 0.074 0.052 CID_128753 | ||
| 0.182 | 0.068 | 0.314 | Sigma receptor agonist | 0.314 0.036 CID_128753 | CID_128753 | |
| 0.156 | 0.046 | 0.156 | Farnesoid X receptor antagonist | |||
| 0.279 | 0.17 | 0.462 | Alpha-glucosidase inhibitor | 0.462 0.092 CID_128753 | CID_128753 | |
| 0.24 | 0.134 | 0.24 | Antithrombotic | |||
| 0.144 | 0.039 | 0.17 | Sphingosine 1-phosphate receptor 4 antagonist | 0.17 0.019 CID_128753 | CID_128753 | |
| 0.159 | 0.057 | 0.159 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.135 0.103 CID_128753 | ||
| 0.126 | 0.024 | 0.126 | Interleukin 12 antagonist | 0.123 0.026 CID_128753 | ||
| 0.196 | 0.095 | 0.196 | Nitric-oxide synthase stimulant | 0.193 0.101 CID_128753 | ||
| 0.252 | 0.156 | 0.311 | Beta lactamase inhibitor | 0.311 0.13 CID_128753 | CID_128753 | |
| 0.149 | 0.052 | 0.186 | M18 aspartyl aminopeptidase inhibitor | 0.186 0.038 CID_128753 | CID_128753 | |
| 0.143 | 0.049 | 0.143 | Platelet activating factor antagonist | |||
| 0.168 | 0.076 | 0.194 | 3C-like protease (Human coronavirus) inhibitor | 0.194 0.055 CID_128753 | CID_128753 | |
| 0.194 | 0.104 | 0.39 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.39 0.04 CID_128753 | CID_128753 | |
| 0.165 | 0.077 | 0.265 | Mcl-1 antagonist | 0.265 0.031 CID_128753 | CID_128753 | |
| 0.169 | 0.081 | 0.188 | Succinate dehydrogenase inhibitor | 0.188 0.059 CID_128753 | CID_128753 | |
| 0.123 | 0.035 | 0.123 | Alpha 2 adrenoreceptor antagonist | |||
| 0.18 | 0.093 | 0.212 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.212 0.063 CID_128753 | CID_128753 | |
| 0.147 | 0.059 | 0.147 | Pregnane X receptor agonist | |||
| 0.244 | 0.159 | 0.387 | GABA C receptor rho-3 antagonist | 0.387 0.067 CID_128753 | CID_128753 | |
| 0.161 | 0.077 | 0.161 | Neurotensin receptor agonist | 0.138 0.135 CID_128753 | ||
| 0.092 | 0.011 | 0.092 | Potassium channel intermediate-conductance Ca-activated blocker | 0.079 0.018 CID_128753 | ||
| 0.097 | 0.017 | 0.097 | Calcium channel T-type blocker | |||
| 0.215 | 0.135 | 0.379 | 12-Lipoxygenase inhibitor | 0.379 0.046 CID_128753 | CID_128753 | |
| 0.128 | 0.048 | 0.134 | Photosensitizer | 0.134 0.042 CID_128753 | CID_128753 | |
| 0.133 | 0.057 | 0.208 | Alkylator | 0.208 0.024 CID_128753 | CID_128753 | |
| 0.163 | 0.088 | 0.163 | Lipocortins synthesis antagonist | |||
| 0.108 | 0.034 | 0.108 | Bile acid receptor antagonist | |||
| 0.115 | 0.042 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.058 CID_128753 | ||
| 0.166 | 0.098 | 0.199 | Anesthetic general | 0.199 0.075 CID_128753 | CID_128753 | |
| 0.116 | 0.048 | 0.121 | Toll-Like receptor 4 antagonist | 0.121 0.043 CID_128753 | CID_128753 | |
| 0.107 | 0.041 | 0.107 | Alpha 1 adrenoreceptor antagonist | |||
| 0.078 | 0.013 | 0.078 | Thromboxane synthase inhibitor | 0.055 0.036 CID_128753 | ||
| 0.188 | 0.124 | 0.188 | Antioxidant | |||
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | |||
| 0.1 | 0.036 | 0.1 | Alpha 1a adrenoreceptor antagonist | |||
| 0.106 | 0.043 | 0.106 | ABCA1 expression enhancer | |||
| 0.139 | 0.077 | 0.139 | Heat shock protein 70 antagonist | 0.135 0.097 CID_128753 | ||
| 0.071 | 0.009 | 0.071 | Potassium channel (ATP-sensitive) activator | |||
| 0.074 | 0.015 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | 0.057 0.031 CID_128753 | ||
| 0.079 | 0.024 | 0.101 | Glutamate (mGluR1) antagonist | 0.101 0.016 CID_128753 | CID_128753 | |
| 0.113 | 0.058 | 0.152 | Multidrug resistance-associated protein 1 inhibitor | 0.152 0.024 CID_128753 | CID_128753 | |
| 0.091 | 0.036 | 0.119 | Histidine decarboxylase inhibitor | 0.119 0.026 CID_128753 | CID_128753 | |
| 0.233 | 0.18 | 0.324 | 15-Lipoxygenase inhibitor | 0.324 0.115 CID_128753 | CID_128753 | |
| 0.141 | 0.092 | 0.141 | Interferon gamma antagonist | 0.138 0.095 CID_128753 | ||
| 0.103 | 0.054 | 0.103 | Antiadrenergic | |||
| 0.082 | 0.034 | 0.082 | Phosphodiesterase III inhibitor | |||
| 0.092 | 0.045 | 0.092 | Neuropeptide Y antagonist | |||
| 0.1 | 0.053 | 0.1 | Adrenaline antagonist | |||
| 0.074 | 0.028 | 0.074 | Nitric oxide donor | |||
| 0.05 | 0.007 | 0.05 | Transforming growth factor beta 2 antagonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | 0.049 0.022 CID_128753 | ||
| 0.097 | 0.058 | 0.097 | Alpha adrenoreceptor antagonist | |||
| 0.201 | 0.164 | 0.277 | Cholesterol antagonist | 0.277 0.106 CID_128753 | CID_128753 | |
| 0.071 | 0.036 | 0.071 | Beta adrenoreceptor antagonist | |||
| 0.147 | 0.113 | 0.147 | Hepatoprotectant | |||
| 0.048 | 0.013 | 0.048 | Glutamate (mGluR8) agonist | 0.048 0.013 CID_128753 | ||
| 0.068 | 0.034 | 0.09 | Biliverdin reductase inhibitor | 0.09 0.022 CID_128753 | CID_128753 | |
| 0.095 | 0.062 | 0.095 | Pim-1 kinase inhibitor | |||
| 0.076 | 0.044 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.09 | 0.06 | 0.09 | Potassium channel activator | |||
| 0.129 | 0.102 | 0.129 | Phospholipase A2 inhibitor | |||
| 0.047 | 0.024 | 0.047 | Glutamate (mGluR4) antagonist | 0.044 0.03 CID_128753 | ||
| 0.063 | 0.04 | 0.063 | TRPA1 antagonist | |||
| 0.114 | 0.094 | 0.171 | Interleukin 4 antagonist | 0.171 0.034 CID_128753 | CID_128753 | |
| 0.104 | 0.084 | 0.104 | Microtubule formation inhibitor | |||
| 0.031 | 0.012 | 0.031 | NMDA receptor glycine site antagonist | |||
| 0.084 | 0.065 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.04 CID_128753 | CID_128753 | |
| 0.056 | 0.039 | 0.056 | Beta 1 adrenoreceptor antagonist | |||
| 0.092 | 0.075 | 0.128 | GABA C receptor rho-1 antagonist | 0.128 0.034 CID_128753 | CID_128753 | |
| 0.061 | 0.045 | 0.061 | NMDA receptor agonist | |||
| 0.171 | 0.155 | 0.222 | Superoxide dismutase inhibitor | 0.222 0.096 CID_128753 | CID_128753 | |
| 0.104 | 0.088 | 0.107 | Calcium channel N-type blocker | 0.107 0.083 CID_128753 | CID_128753 | |
| 0.079 | 0.063 | 0.079 | Glutathione S-transferase inhibitor | 0.079 0.063 CID_128753 | ||
| 0.06 | 0.045 | 0.06 | NMDA receptor glycine site agonist | |||
| 0.14 | 0.125 | 0.14 | Psychostimulant | |||
| 0.089 | 0.075 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.103 0.057 CID_128753 | CID_128753 | |
| 0.072 | 0.059 | 0.097 | GABA aminotransferase inhibitor | 0.097 0.029 CID_128753 | CID_128753 | |
| 0.036 | 0.024 | 0.036 | Progesterone antagonist | |||
| 0.08 | 0.07 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.064 | 0.054 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.166 | 0.158 | 0.352 | Streptokinase A inhibitor | 0.352 0.061 CID_128753 | CID_128753 | |
| 0.025 | 0.017 | 0.026 | Kainate receptor 4 antagonist | 0.026 0.016 CID_128753 | CID_128753 | |
| 0.089 | 0.083 | 0.089 | Mediator release inhibitor | |||
| 0.068 | 0.063 | 0.095 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.095 0.04 CID_128753 | CID_128753 | |
| 0.047 | 0.043 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.04 | 0.036 | 0.062 | GABA B receptor antagonist | 0.062 0.011 CID_128753 | CID_128753 | |
| 0.038 | 0.036 | 0.038 | Kainate receptor agonist | |||
| 0.092 | 0.09 | 0.098 | Factor V inhibitor | 0.098 0.074 CID_128753 | CID_128753 | |
| 0.052 | 0.053 | 0.061 | Androgen agonist | 0.061 0.039 CID_128753 | CID_128753 | |
| 0.045 | 0.047 | 0.059 | CD45 antagonist | 0.059 0.023 CID_128753 | CID_128753 | |
| 0.062 | 0.065 | 0.111 | Porphobilinogen synthase inhibitor | 0.111 0.031 CID_128753 | CID_128753 | |
| 0.023 | 0.026 | 0.03 | NMDA 2D receptor antagonist | 0.03 0.016 CID_128753 | CID_128753 | |
| 0.077 | 0.082 | 0.097 | Triose-phosphate isomerase inhibitor | 0.097 0.051 CID_128753 | CID_128753 | |
| 0.074 | 0.08 | 0.095 | Thioredoxin reductase inhibitor | 0.095 0.033 CID_128753 | CID_128753 | |
| 0.09 | 0.096 | 0.101 | GABA C receptor antagonist | 0.101 0.076 CID_128753 | CID_128753 | |
| 0.143 | 0.152 | 0.294 | Histone acetyltransferase inhibitor | 0.294 0.015 CID_128753 | CID_128753 | |
| 0.057 | 0.067 | 0.077 | Transcription factor RelA inhibitor | 0.077 0.02 CID_128753 | CID_128753 | |
| 0.026 | 0.038 | 0.041 | Catechol O-methyltransferase inhibitor | 0.041 0.013 CID_128753 | CID_128753 | |
| 0.036 | 0.049 | 0.046 | AICAR transformylase inhibitor | 0.046 0.027 CID_128753 | CID_128753 | |
| 0.096 | 0.109 | 0.13 | M17 leucyl aminopeptidase inhibitor | 0.13 0.069 CID_128753 | CID_128753 | |
| 0.043 | 0.057 | 0.067 | Alcohol oxidase inhibitor | 0.067 0.03 CID_128753 | CID_128753 | |
| 0.075 | 0.09 | 0.249 | Breast cancer-resistant protein inhibitor | 0.249 0.009 CID_128753 | CID_128753 | |
| 0.1 | 0.116 | 0.163 | Alkaline phosphatase inhibitor | 0.163 0.052 CID_128753 | CID_128753 | |
| 0.167 | 0.184 | 0.185 | Transcription factor STAT3 inhibitor | 0.185 0.156 CID_128753 | CID_128753 | |
| 0.204 | 0.224 | 0.248 | Antibacterial | 0.248 0.179 CID_128753 | CID_128753 | |
| 0.256 | 0.277 | 0.306 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.306 0.205 CID_128753 | CID_128753 | |
| 0.164 | 0.188 | 0.396 | Prostaglandin dehydrogenase inhibitor | 0.396 0.068 CID_128753 | CID_128753 | |
| 0.072 | 0.097 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.052 CID_128753 | CID_128753 | |
| 0.094 | 0.12 | 0.103 | Cathepsin H inhibitor | 0.103 0.101 CID_128753 | CID_128753 | |
| 0.082 | 0.109 | 0.133 | Interleukin 1b antagonist | 0.133 0.053 CID_128753 | CID_128753 | |
| 0.117 | 0.149 | 0.198 | DNA methyltransferase I inhibitor | 0.198 0.07 CID_128753 | CID_128753 | |
| 0.051 | 0.084 | 0.071 | Interferon inducer | 0.071 0.034 CID_128753 | CID_128753 | |
| 0.072 | 0.105 | 0.084 | Thioredoxin inhibitor | 0.084 0.073 CID_128753 | CID_128753 | |
| 0.049 | 0.084 | 0.057 | Ryanodine receptor antagonist | 0.057 0.046 CID_128753 | CID_128753 | |
| 0.05 | 0.085 | 0.06 | Bcl-xL inhibitor | 0.06 0.04 CID_128753 | CID_128753 | |
| 0.057 | 0.096 | 0.063 | MDM2 inhibitor | 0.063 0.061 CID_128753 | CID_128753 | |
| 0.03 | 0.076 | 0.055 | Dihydroorotate dehydrogenase inhibitor | 0.055 0.033 CID_128753 | CID_128753 | |
| 0.067 | 0.115 | 0.092 | Interleukin 5 antagonist | 0.092 0.052 CID_128753 | CID_128753 | |
| 0.072 | 0.121 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.069 CID_128753 | CID_128753 | |
| 0.011 | 0.061 | 0.023 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 CID_128753 | CID_128753 | |
| 0.028 | 0.078 | 0.051 | Nerve growth factor antagonist | 0.051 0.017 CID_128753 | CID_128753 | |
| 0.072 | 0.124 | 0.288 | Anesthetic local | 0.288 0.014 CID_128753 | CID_128753 | |
| 0.012 | 0.065 | 0.028 | AMPA 2 receptor antagonist | 0.028 0.022 CID_128753 | CID_128753 | |
| 0.055 | 0.112 | 0.082 | Interferon agonist | 0.082 0.05 CID_128753 | CID_128753 | |
| 0.218 | 0.276 | 0.29 | 5 Hydroxytryptamine release inhibitor | 0.29 0.176 CID_128753 | CID_128753 | |
| 0.042 | 0.106 | 0.082 | Na+ K+ transporting ATPase inhibitor | 0.082 0.049 CID_128753 | CID_128753 | |
| 0.098 | 0.164 | 0.219 | Dual specificity phosphatase 3 inhibitor | 0.219 0.051 CID_128753 | CID_128753 | |
| 0.021 | 0.091 | 0.052 | Angiotensin AT1 receptor antagonist | 0.052 0.014 CID_128753 | CID_128753 | |
| 0.039 | 0.11 | 0.073 | Purinergic P2X1 antagonist | 0.073 0.03 CID_128753 | CID_128753 | |
| 0.042 | 0.117 | 0.077 | Bcl2 antagonist | 0.077 0.034 CID_128753 | CID_128753 | |
| 0.028 | 0.103 | 0.056 | GABA A receptor antagonist | 0.056 0.034 CID_128753 | CID_128753 | |
| 0.034 | 0.116 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | 0.071 0.044 CID_128753 | CID_128753 | |
| 0.08 | 0.162 | 0.213 | Toll-Like receptor antagonist | 0.213 0.026 CID_128753 | CID_128753 | |
| 0.018 | 0.101 | 0.039 | Angiotensin II receptor antagonist | 0.039 0.015 CID_128753 | CID_128753 | |
| 0.137 | 0.221 | 0.278 | Thyroid hormone beta antagonist | 0.278 0.1 CID_128753 | CID_128753 | |
| 0.096 | 0.182 | 0.144 | Heat shock protein 90 alpha antagonist | 0.144 0.093 CID_128753 | CID_128753 | |
| 0.077 | 0.163 | 0.167 | Toll-Like receptor 9 antagonist | 0.167 0.053 CID_128753 | CID_128753 | |
| 0.137 | 0.225 | 0.287 | Thyroid hormone antagonist | 0.287 0.1 CID_128753 | CID_128753 | |
| 0.027 | 0.115 | 0.053 | GABA receptor antagonist | 0.053 0.04 CID_128753 | CID_128753 | |
| 0.018 | 0.108 | 0.06 | AMPA receptor antagonist | 0.06 0.025 CID_128753 | CID_128753 | |
| 0.097 | 0.19 | 0.177 | Dual specificity phosphatase inhibitor | 0.177 0.069 CID_128753 | CID_128753 | |
| 0.089 | 0.184 | 0.157 | Hexokinase inhibitor | 0.157 0.071 CID_128753 | CID_128753 | |
| 0.048 | 0.145 | 0.078 | Calcium channel P-type blocker | 0.078 0.017 CID_128753 | CID_128753 | |
| 0.078 | 0.18 | 0.204 | Interleukin 1 antagonist | 0.204 0.031 CID_128753 | CID_128753 | |
| 0.189 | 0.291 | 0.326 | Apoptosis agonist | 0.326 0.155 CID_128753 | CID_128753 | |
| 0.121 | 0.224 | 0.356 | DNA damaging | 0.356 0.039 CID_128753 | CID_128753 | |
| 0.154 | 0.277 | 0.222 | Histamine release inhibitor | 0.222 0.179 CID_128753 | CID_128753 | |
| 0.148 | 0.272 | 0.207 | Sodium/bile acid cotransporter inhibitor | 0.207 0.179 CID_128753 | CID_128753 | |
| 0.09 | 0.219 | 0.154 | DNA methylase inhibitor | 0.154 0.114 CID_128753 | CID_128753 | |
| 0.052 | 0.191 | 0.21 | Glutamate receptor antagonist | 0.21 0.023 CID_128753 | CID_128753 | |
| 0.065 | 0.206 | 0.13 | NADPH oxidase inhibitor | 0.13 0.071 CID_128753 | CID_128753 | |
| 0.035 | 0.179 | 0.078 | Potassium channel (Ca-activated) activator | 0.078 0.077 CID_128753 | CID_128753 | |
| 0.073 | 0.225 | 0.334 | Pyruvate kinase inhibitor | 0.334 0.039 CID_128753 | CID_128753 | |
| 0.08 | 0.236 | 0.107 | DNA repair enzyme inhibitor | 0.107 0.104 CID_128753 | CID_128753 | |
| 0.17 | 0.341 | 0.272 | MAP kinase 1 inhibitor | 0.272 0.21 CID_128753 | CID_128753 | |
| 0.033 | 0.206 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.074 0.05 CID_128753 | CID_128753 | |
| 0.03 | 0.21 | 0.097 | Glutamate (mGluR group I) antagonist | 0.097 0.027 CID_128753 | CID_128753 | |
| 0.102 | 0.284 | 0.139 | Catenin beta inhibitor | 0.139 0.133 CID_128753 | CID_128753 | |
| 0.038 | 0.233 | 0.151 | Glycogen synthase kinase-3 alpha inhibitor | 0.151 0.066 CID_128753 | CID_128753 | |
| 0.097 | 0.314 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.116 CID_128753 | CID_128753 | |
| 0.091 | 0.312 | 0.22 | Lipoxygenase inhibitor | 0.22 0.121 CID_128753 | CID_128753 | |
| 0.024 | 0.275 | 0.107 | Glutamate (mGluR) antagonist | 0.107 0.031 CID_128753 | CID_128753 | |
| 0.046 | 0.305 | 0.11 | Antibacterial (Helicobacter pylori) | 0.11 0.098 CID_128753 | CID_128753 | |
| 0.042 | 0.346 | 0.114 | Cytokine production inhibitor | 0.114 0.096 CID_128753 | CID_128753 | |
| 0.046 | 0.402 | 0.163 | Platelet adhesion inhibitor | 0.163 0.093 CID_128753 | CID_128753 | |
| 0.012 | 0.445 | 0.096 | 5-Lipoxygenase inhibitor | 0.096 0.067 CID_128753 | CID_128753 | |
| 0.02 | 0.515 | 0.081 | Viral attachment inhibitor | 0.081 0.047 CID_128753 | CID_128753 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |